Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
| - | Shown here is the interaction between paclitaxel and the protein via <scene name='Sandbox_reserved_394/Hydrogen_bonds/ | + | Shown here is the interaction between paclitaxel and the protein via <scene name='Sandbox_reserved_394/Hydrogen_bonds/4'>hydrogen bonding</scene>. The hydrogen bond is formed between an oxygen (red) from the sulfoxone portion of the drug to an "N-H" group (grey) of a glycine amino acid. |
Shown here is the <scene name='Sandbox_reserved_394/Hydrophobic_bonding/3'>hydrophobic bonding</scene> formed between the protein (grey) and a hydrophobic portion of paclitaxel (blue). | Shown here is the <scene name='Sandbox_reserved_394/Hydrophobic_bonding/3'>hydrophobic bonding</scene> formed between the protein (grey) and a hydrophobic portion of paclitaxel (blue). | ||
</StructureSection> | </StructureSection> | ||
Revision as of 17:57, 19 September 2012
== Paclitaxel in Apoptosis ==
| |||||||||||
